| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 11ZYL7QK34 |
| InChI Key | RUJBDQSFYCKFAA-OAHLLOKOSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C22H26N2O4 |
| Molecular Weight | 382.46 |
| AlogP | 4.44 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 61.64 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 28.0 |
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Gout; Hyperuricemia | Phase 2 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2107351 |
| FDA SRS | 11ZYL7QK34 |
| PubChem | 7048810 |
| SureChEMBL | SCHEMBL5431173 |
| ZINC | ZINC000003831552 |